News

The Citizen CPR Foundation has launched free, monthly coaching webinars to help civic leaders and emergency response planners build a coordinated preparation and response system to help save lives from sudden cardiac arrest (SCA)...

Withings plans to grow its business-to-business division and to develop the next generation of tracking devices to monitor and predict health conditions Withings, early pioneers of the connected health revolution, has announced a $60...

Pulsara, the leading telehealth and communication platform that connects teams across organizations, announced that the company has been named a compatible vendor within the American Heart Association Get With The Guidelines® program. This...

  With Innovative Health’s landmark clearances to reprocess the St. Jude Medical BRK Transseptal Needle and the Baylis Medical NRG Transseptal Needle, EP labs have the potential to realize significant new savings through single-use device...

U.S. News & World Report, the global authority in hospital rankings, released the 2020-21 Best Hospitals rankings. The 31st edition includes special recognition of the herculean efforts being mounted by the nation's health professionals...

Transformative, a healthcare startup whose software predicts sudden cardiac arrest, announced that it has raised a $1.7 million seed round, led by Tera Ventures. The round includes funding from the Wellcome Trust, which provided...

RealView Imaging Ltd. announced the completion of its $10M series C financing round. New investors in this round include OurCrowd, a major hi-tech venture capital fund, Judith and Kobi Richter, among the most prominent technology and medical...

Caption Health, a leader in medical AI technology, has received FDA 510(k) clearance for an updated version of Caption Interpretation™, which enables clinicians to obtain quick, easy and accurate measurements of cardiac ejection fraction (EF)...

World's first single-use two channel ECG and heart rate biosensor provides 72-hour patient monitoring with remote data access in ambulatory, hospital and home settings LifeSignals Group announced USFDA 510(k) clearance has been received for...

- Recently completed NODE-301 and ongoing NODE-301B studies can be used as two efficacy studies supporting a future NDA submission (target p-values of <0.05) - NODE-301B, renamed the RAPID study, will reopen to enrollment and incorporate...